126 related articles for article (PubMed ID: 31854474)
1. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia.
Bigas A; Guillén Y; Schoch L; Arambilet D
Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.
Kaveri D; Kastner P; Dembélé D; Nerlov C; Chan S; Kirstetter P
Blood; 2013 Aug; 122(5):694-704. PubMed ID: 23801632
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
Biomed Pharmacother; 2024 Jan; 170():116013. PubMed ID: 38104416
[TBL] [Abstract][Full Text] [Related]
5. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling.
Liu X; Liu S; Chen J; He L; Meng X; Liu S
Ann Hematol; 2016 Oct; 95(11):1787-93. PubMed ID: 27506924
[TBL] [Abstract][Full Text] [Related]
6. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
7. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
8. Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling.
Giambra V; Jenkins CE; Lam SH; Hoofd C; Belmonte M; Wang X; Gusscott S; Gracias D; Weng AP
Blood; 2015 Jun; 125(25):3917-27. PubMed ID: 25934477
[TBL] [Abstract][Full Text] [Related]
9. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway.
Ma Y; Li Y; Huang M; Meng Y
J Chemother; 2023 May; 35(3):240-249. PubMed ID: 35666085
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.
Gekas C; D'Altri T; Aligué R; González J; Espinosa L; Bigas A
Leukemia; 2016 Oct; 30(10):2002-2010. PubMed ID: 27125305
[TBL] [Abstract][Full Text] [Related]
12. [Genetic Polymorphisms in Wnt Signaling Pathway and Acute Leukemia].
Zhang LJ; Zhou J; Ye YX; Lu XJ; Jiang H; Mao ZG; Zeng SG; Ying BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):403-8. PubMed ID: 26121862
[TBL] [Abstract][Full Text] [Related]
13. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
[TBL] [Abstract][Full Text] [Related]
14. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
[TBL] [Abstract][Full Text] [Related]
16. γ-Catenin-Dependent Signals Maintain BCR-ABL1
Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis.
Tan Y; Sementino E; Liu Z; Cai KQ; Testa JR
Sci Rep; 2020 Sep; 10(1):15837. PubMed ID: 32985581
[TBL] [Abstract][Full Text] [Related]
18. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia.
Chiarini F; Paganelli F; Martelli AM; Evangelisti C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046053
[TBL] [Abstract][Full Text] [Related]
19. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
[TBL] [Abstract][Full Text] [Related]
20. Long-noncoding RNA HOTAIR inhibits immunologic rejection of mouse leukemia cells through activating the Wnt/β-catenin signaling pathway in a mouse model of leukemia.
Li GJ; Ding H; Miao D
J Cell Physiol; 2019 Jul; 234(7):10386-10396. PubMed ID: 30609034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
